"Johns Hopkins Children’s Center brings the collaborative multidisciplinary might and expertise of this venerable institution to bear in treating every child who comes through its doors."

During the past decade, Johns Hopkins Children's Center conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 10 clinical trials were completed, i.e. on average, 76.9% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 7 clinical trials were completed. i.e. 77.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Johns Hopkins Children's Center" #1 sponsor was "National Institute of Allergy and Infectious Diseases (NIAID)" with 22 trials, followed by "Johns Hopkins University" with 7 trials sponsored, "Genzyme, a Sanofi Company" with 2 trials sponsored, "PTC Therapeutics" with 2 trials sponsored and "University of Pennsylvania" with 2 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Johns Hopkins Children's Center" #1 collaborator was "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 10 trials as a collaborator, "Glaxo Wellcome" with 6 trials as a collaborator, "Johns Hopkins University" with 4 trials as a collaborator, "Baylor College of Medicine" with 3 trials as a collaborator and "Children's Hospital Los Angeles" with 3 trials as a collaborator. Other collaborators include 99 different institutions and companies that were collaborators in the rest 87 trials.

According to Clinical.Site data, the most researched conditions in "Johns Hopkins Children's Center" are "HIV Infections" (23 trials), "Pregnancy" (5 trials), "Cardiac Arrest" (2 trials), "Cystic Fibrosis" (2 trials) and "HIV Seronegativity" (2 trials). Many other conditions were trialed in "Johns Hopkins Children's Center" in a lesser frequency.

Most popular intervention types in "Johns Hopkins Children's Center" are "Drug" (27 trials), "Other" (6 trials), "Behavioral" (4 trials), "Device" (4 trials) and "Procedure" (4 trials). Other intervention types were less common.

The name of intervention was led by "Zidovudine" (10 trials), "Nevirapine" (7 trials), "Didanosine" (6 trials), "Lamivudine" (4 trials) and "Nelfinavir mesylate" (4 trials). Other intervention names were less common.

The vast majority of trials in "Johns Hopkins Children's Center" are 48 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Johns Hopkins Children's Center". undefined are not yet recruiting, 5 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 42 completed trials in Johns Hopkins Children's Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Johns Hopkins Children's Center, 6 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 9 trials that are defined as “Not Applicable".